Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug for Flu Prevention
Merck’s Cidara Therapeutics acquisition brings a lead program with potential to become a first-in-class drug…
Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug for Flu Prevention
Merck’s Cidara Therapeutics acquisition brings a lead program with potential to become a first-in-class drug for preventing influenza infection. A Phase 3 study is already underway, timed to coincide with the start of the flu season in the Northern Hemisphere. The post Merck Makes Big Antiviral Move With $9B Deal to Land Cidara’s Late-Stage Drug…
Will Trump’s Team Slow Supersized Health Mergers?
Rising health care costs and the impending expiration of expanded Obamacare subsidies fueled the record-setting government shutdown that ended this week. But there’s another driver of escalating costs and prices playing out in a far broader, more impactful way: the rapid consolidation of insurers, hospital systems, doctors’ groups, and pharmacies into behemoths, effectively giving them…
Bridging the Gap Between Data and Quality Improvement for Hospitals
Data only drives change when the right people see the right numbers at the right time and someone owns the follow-through. The post Bridging the Gap Between Data and Quality Improvement for Hospitals appeared first on MedCity News.
How to Choose the Right Dental Supply Company for Your Practice
[Sponsored] With the right dental supplier, you can ensure your practice’s efficiency and profitability. Learn what to consider and how a modern, direct-to-practitioner model can benefit you. The post How to Choose the Right Dental Supply Company for Your Practice appeared first on MedCity News.
AI Companies That Invest in Better Data Pipelines are Winning Faster Regulatory Approvals — Here’s Why
Medical AI developers who prioritize data early will be the ones crossing the regulatory finish line faster and more reliably. The post AI Companies That Invest in Better Data Pipelines are Winning Faster Regulatory Approvals — Here’s Why appeared first on MedCity News.
What Excites Zimmer Biomet’s CIO About MedTech Right Now?
Shaun Braun, Zimmer Biomet’s chief information and technology officer, said today’s biggest medtech innovation is the field’s focus on connection and interoperability. By integrating data, AI and robotics into a single ecosystem, the company is seeking to deliver more personalized care and improve surgical outcomes. The post What Excites Zimmer Biomet’s CIO About MedTech Right…
Represión de Trump empuja a inmigrantes víctimas de violencia doméstica a las sombras
Línea de ayuda nacional para casos de violencia doméstica: Las personas que han sufrido abuso doméstico pueden recibir ayuda confidencial en thehotline.org o llamando al 800-799-7233. La inmigrante originaria de India le creyó a su esposo cuando le dijo por teléfono que la mataría, si todavía estaba en su casa de Georgia para cuando él…
Conflicting Advice on Covid Shots Likely To Ding Already Low Vaccine Rates, Experts Warn
More than three-quarters of American adults didn’t get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations. The covid vaccine was initially popular. About 75% of Americans had received at least one dose of the first versions of the vaccine by early 2022,…
Listen: New Federal Guidelines Could Weaken Consumer Protections Against Medical Debt
LISTEN: Bad credit can keep you from getting a job, a car loan, or an apartment to rent. For many Americans, health care debt is to blame. KFF Health News senior correspondent Noam N. Levey appeared on WAMU’s “Health Hub” on Nov. 12 to explain why new federal guidelines on health care debt and credit…
KFF Health Tracking Poll: Prescription Drug Costs, Views on Trump Administration Actions, and GLP-1 Use
About one in eight adults say that they are currently taking a GLP-1 drug either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern. Few adults think it is likely their prescription costs will go down as a result of…
